Search

everythinglearnresearchcommunity

for

Search:↓

EBGS reduces platelet adhesion, potentially helping prevent blood clots.

Fexofenadine reduces discomfort but doesn't significantly improve hair regrowth in Alopecia Areata treatment.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

Biologics for severe asthma have known side effects, but some new risks need more study.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

The F9 formulation of Finasteride tablets, using Eudragit, successfully controlled drug release.

Oral minoxidil may have more cardiovascular risks than topical minoxidil.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

A method was developed to test the breakdown of Finasteride capsules, showing it can tell the difference between different brands and highlighting the need for standard tests and ingredient consistency.

Companies agreed to stop false advertising about their products' health benefits.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

A 6-year-old girl had a rare allergic reaction to a hair regrowth treatment.

Fibrinogen/LDL apheresis may improve speech perception in sudden hearing loss, especially for those with high fibrinogen and LDL levels.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

HPV vaccines are generally safe but need further investigation for rare side effects.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Oral minoxidil helps hair growth, is cost-effective, and mostly well-tolerated.

PRP treatment satisfies 58% of female hair loss patients, with most noticing fuller, thicker hair and less shedding.

The symptoms described align more with Haberland syndrome, not Delleman-Oorthuys syndrome.

Low quality of life and high HSS-29 scores increase risk of losing patients during treatment.